Sapience Therapeutics, Inc. — Form D
Sapience Therapeutics, Inc. of HARRISON, NY, a company, filed a Form D exempt-offering notice with the SEC on 2016-01-11. The offering totals $1.0M, of which $300K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-01-11
- Form: D
- Accession: 0001140361-16-047412
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $300K
- Remaining: $700K
- Investors: 3
- Date of first sale: 2015-12-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-254854
Issuer
- Name: Sapience Therapeutics, Inc.
- CIK: 0001661731
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 500 MAMARONECK AVENUE, HARRISON, NY, 10528
- Phone: (914) 607-6931
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Robert Ruffolo | Director | Boston, MA |
| Christian Schade | Director | Harrison, NY |
| Barry Kappel | Director | Harrison, NY |
| Barry Kappel | Executive Officer | Harrison, NY |
| David Scheinberg | Director | Harrison, NY |
| Howard Pien | Director | Harrison, NY |
| Isaac Blech | Director | Jupiter, FL |
| Robert Ruffolo, Ph.D. | Director | Scarsdale, NY |
| Barry Kappel, Ph.D. | Director | Scarsdale, NY |
| Barry Kappel, Ph.D. | Executive Officer | Scarsdale, NY |
| David Scheinberg, Ph.D. | Director | Scarsdale, NY |
Other filings by this issuer (2)
More